# Improving the Care of Incontinence-Associated Dermatitis (IAD) Using a Beta-Glucan Cream as a Hydrating and Soothing Agent

> **NCT07524439** · NA · NOT_YET_RECRUITING · sponsor: **University of Alberta** · enrollment: 60 (estimated)

## Conditions studied

- Fecal Incontinence
- Urinary Incontinence
- Diaper Rash
- Irritant Contact Dermatitis Caused by Faeces
- Irritant Contact Dermatitis

## Interventions

- **DRUG:** Soothing Beta Cream (Dr. Mom)
- **OTHER:** Standard of Care

## Key facts

- **NCT ID:** NCT07524439
- **Lead sponsor:** University of Alberta
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05-01
- **Primary completion:** 2027-05-01
- **Final completion:** 2028-11-30
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07524439

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07524439, "Improving the Care of Incontinence-Associated Dermatitis (IAD) Using a Beta-Glucan Cream as a Hydrating and Soothing Agent". Retrieved via AI Analytics 2026-09-10 from https://api.ai-analytics.org/clinical/NCT07524439. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*